Concepedia

Sharon Gray

SG

Statistics

Publications

20

Citations

2.2K

H-Index

15

Active since

2007

Affiliations

Pfizer (United States)(Current)

University of Bristol

Kaiser Permanente

Summa Health System

Northeast Ohio Medical University

Sharon Gray is an author at Pfizer (United States) specializing in infectious diseases, immunization, and bacterial infections.

Publications per year

2007–2023

20

Publications

20

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof, Jeff Slezak, Heidi Fischer et al. · The Lancet · 2021 · 1.3K citations · Full text

, , +15

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

Catherine Hyams, Robert Challen, Robin Marlow et al. · The Lancet Regional Health - Europe · 2022 · 172 citations · Full text

, , +15

Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study

Sara Y. Tartof, Jeff Slezak, Laura Puzniak et al. · The Lancet Regional Health - Americas · 2022 · 117 citations · Full text

, , +14

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia

Robert Sherwin, Sharon Gray, Ronika Alexander et al. · The Journal of Infectious Diseases · 2013 · 95 citations

, , +16

Surveillance for Invasive Pneumococcal Disease During 2000–2005 in a Population of Children Who Received 7-Valent Pneumococcal Conjugate Vaccine

Steven Black, Eric K. France, Daniel J. Isaacman et al. · The Pediatric Infectious Disease Journal · 2007 · 84 citations

, , +17

1–5 of 20